Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Shares Issued (2016 - 2025)

Rein Therapeutics (RNTX) has disclosed Shares Issued for 8 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 117.83% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 1015.38% year-over-year, with the annual reading at $1.6 million for FY2025, 1015.38% up from the prior year.
  • Shares Issued for Q4 2025 was $1.2 million at Rein Therapeutics, up from -$345000.0 in the prior quarter.
  • The five-year high for Shares Issued was $55.6 million in Q1 2021, with the low at -$55.6 million in Q2 2021.
  • Average Shares Issued over 3 years is $181200.0, with a median of $63500.0 recorded in 2021.
  • Peak annual rise in Shares Issued hit 9973.19% in 2021, while the deepest fall reached 597.02% in 2021.
  • Over 3 years, Shares Issued stood at $1000.0 in 2021, then tumbled by 688800.0% to -$6.9 million in 2024, then skyrocketed by 117.83% to $1.2 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1.2 million, -$345000.0, and $712000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.